ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.83
0.43%
US Tech 100
17,169.20
1.83%
S&P 500
5,064.20
0.91%
US Dollar vs CAD
1.36675
-0.41%
Bitcoin
59,226.50
1.70%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Avalo Therapeutics Inc (AVTX)

  7. Avalo Therapeutics Inc (AVTX) News

AVTX Avalo Therapeutics Inc

15.50
-0.50 (-3.12%)
After Hours
Last Updated: 18:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Avalo Therapeutics Inc AVTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.50 -3.12% 15.50 18:00:00
Open Price Low Price High Price Close Price Previous Close
16.20 15.39 17.42 15.39 16.00
more quote information »

Recent News

Date Time Source Heading
4/02/202406:00GLOBEAvalo Therapeutics Appoints Biotech Leaders to Board of..
3/29/202415:01GLOBEAvalo Reports 2023 Financial Results and Provides Business..
3/27/202415:01GLOBEAvalo Acquires Anti-IL-1β mAb and Announces Private..
2/14/202420:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202409:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/31/202415:01EDGAR2Form 8-K - Current report
12/28/202316:05EDGAR2Form 8-K - Current report
12/27/202306:00GLOBEAvalo Therapeutics Announces 1-for-240 Reverse Stock Split
12/21/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/21/202315:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/20/202315:01EDGAR2Form 8-K - Current report
12/07/202306:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/07/202306:01EDGAR2Form 8-K - Current report
12/07/202306:00GLOBEAvalo Encourages Stockholders to Vote FOR the Reverse Stock..
11/16/202306:15EDGAR2Form 8-K - Current report
11/09/202306:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202306:04EDGAR2Form 8-K - Current report
11/09/202306:00GLOBEAvalo Reports Third Quarter 2023 Financial Results and..
10/31/202306:21EDGAR2Form 8-K - Current report
10/31/202306:00GLOBEAvalo Completes Divestiture of AVTX-800 Series
10/19/202315:15EDGAR2Form ARS - Annual Report to Security Holders
10/19/202315:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/19/202315:01EDGAR2Form DEF 14A - Other definitive proxy statements
10/17/202315:02EDGAR2Form 8-K - Current report
10/05/202315:02EDGAR2Form PRE 14A - Other preliminary proxy statements
9/26/202306:04EDGAR2Form 8-K - Current report
9/26/202306:00GLOBEAvalo Therapeutics Successfully Eliminates $35 Million Debt..
9/13/202315:03EDGAR2Form 8-K - Current report
9/13/202308:12EDGAR2Form 8-K - Current report
9/12/202306:10EDGAR2Form 8-K - Current report
9/12/202306:00GLOBEAvalo Enters into Agreement to Divest AVTX-800 Series
9/11/202306:22EDGAR2Form 8-K - Current report
9/06/202306:00GLOBEAvalo to Present at the H.C. Wainwright 25th Annual Global..
8/14/202315:23EDGAR2Form 8-K - Current report
8/08/202315:11EDGAR2Form 8-K - Current report
8/07/202316:27EDGAR2Form 8-K - Current report
8/07/202316:26EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
8/03/202306:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/202306:01EDGAR2Form 8-K - Current report
8/03/202306:00GLOBEAvalo Reports Second Quarter 2023 Financial Results and..
7/21/202307:25EDGAR2Form 8-K - Current report
7/06/202315:01GLOBEAvalo to Participate in SVB Securities Therapeutics Forum
6/29/202307:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
6/28/202317:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/26/202306:00GLOBEAvalo Announces Topline Data from Phase 2 PEAK Trial for..
6/01/202306:00GLOBEAvalo to Present at the Jefferies Healthcare Conference
5/22/202306:00GLOBEAvalo Announces Appointment of Michael Croft, Ph.D. and Jeff..
5/15/202306:00GLOBEAvalo to Present at ATS 2023 Respiratory Innovation Summit
5/10/202306:00GLOBEAvalo to Present at the 2023 RBC Capital Markets Global..
5/04/202315:01GLOBEAvalo Reports First Quarter 2023 Financial Results and..

Your Recent History

NASDAQ
AVTX
Avalo Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved